Kaunas University of Medicine
Kaunas, 44307, Lithuania
NCT Number: NCT00528476
The purpose of this study is to determine clinical and urodynamic risk factors for recurrent urinary tract infection in 5-18 years old children.
Looking for future studies?
Notify Me5 year–18 year
All sexes
Observational
Kaunas, 44307, Lithuania
It is known, that in the group of young children the most common reason of recurrent UTI is anatomic abnormalities, such as vesicoureteral reflux, hydronephrosis. However, not all recurrent UTI can be explained by anatomic abnormalities. The vast majority of school age children with recurrent UTI have anatomically normal urinary tract. Recent studies discuss about the role of behavioral and functional abnormalities (inadequate fluid intake, stool retention, infrequent voiding, etc.) that can predispose recurrent urinary tract infections. Influence of some these abnormalities for recurrent UTI is controversial. Family history, behavioral and functional abnormalities which predispose to urinary tract infections in children with normal urinary tract are neglected in most protocols of urinary tract infection.
Children in this study receive a careful evaluation including complete history, voiding-drinking diary, bowel questionnaire, physical investigation, sonography, voiding cystourethrogram.
Follow up time - 1 year. Urinalysis once a month and during each episode of fever.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Kaunas University of Medicine
Other
Role of Clinical and Urodynamic Risk Factors for Recurrent Urinary Tract Infection in 5-18 Years Old Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01861353
Cystitis, Female Urogenital Diseases
Oulu, Finland
View Trial DetailsNCT02598362
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Brussels, Belgium
View Trial DetailsNCT01346774
Cystitis, Female Urogenital Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT06822751
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystitis
Elbeuf, France
View Trial Details